MedTrace Logo

Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries

NCT05245721 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-02-18

No results posted yet for this study

Summary

Effect of caudal nalbuphine on postoperative emergence agitation in pediatrics undergoing infra-umbilical surgeries and pain assessment

Conditions

  • Agitation, Emergence
  • Post Operative Pain

Interventions

DRUG

Nalbuphine

Caudal nalbuphine injection in pediatrics undergoing infra-umbilical surgeries

DRUG

Bupivacain

Caudal bupivacaine in pediatrics undergoing infra-umbilical surgeries

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-01-31
Completion
2023-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05245721 on ClinicalTrials.gov